Embryo-fetal distribution of a biopharmaceutical IgG2 during rat organogenesis

Reproductive Toxicology

Volumn 34, Issue 1, 2012, Pages 66-72

  Bowman, C J ^a   King, L E ^a   Stedman, D B ^a  

^a PFIZER INC   (United States)

Author keywords

Biodistribution; Biopharmaceutical; IgG; Monoclonal antibodies; Placental transfer

Indexed keywords

IMMUNOGLOBULIN G2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY FLUID; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG DOSE INCREASE; DRUG TISSUE LEVEL; EMBRYO; EMBRYO DEVELOPMENT; EMBRYONAL TISSUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FETUS; FETUS BLOOD; FETUS DEVELOPMENT; GESTATION PERIOD; IMMUNOGLOBULIN G2 BLOOD LEVEL; NONHUMAN; ORGANOGENESIS; RAT;

ANIMALS; ANTIBODIES, MONOCLONAL, HUMANIZED; EMBRYO, MAMMALIAN; FEMALE; FETUS; IMMUNOGLOBULIN G; MATERNAL-FETAL EXCHANGE; ORGANOGENESIS; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION;

RATTUS;

EID: 84861668182     PISSN: 08906238     EISSN: 18731708     Source Type: Journal    
DOI: 10.1016/j.reprotox.2012.04.004     Document Type: Article

References (21)

1. Martin P.L., Weinbauer G.F. Developmental toxicity testing of biopharmaceuticals in non-human primates: previous experience and future directions. International Journal of Toxicology 2010, 29:552-568.
2. Brambell F.W.R. The transmission of passive immunity from mother to young. Frontiers of biology 1970, 80-141. North-Holland Publishing Co, Amsterdam. F.W.R. Brambell (Ed.).
3. Halliday R. Prenatal and postnatal transmission of passive immunity to young rats. Proceedings of the Royal Society of London Series B 1955, 144:427-430.
4. PentŠuk N., van der Laan J.W. An interspecies comparison of placental antibody transfer: new insights into developmental toxicity testing of monoclonal antibodies. Birth Defects Research Part B: Developmental and Reproductive Toxicology 2009, 86:328-344.
5. DeSesso J.M., Williams A.L., Ahuja A., Bowman C.J., Hurtt M.E. The placenta, transfer of immunoglobulins, and safety assessment of biopharmaceuticals in pregnancy. Critical Reviews in Toxicology 2012, 42:185-210.
6. Morphis L.G., Gitlin D. Maturation of the maternofoetal transport system for (-globulin in the mouse. Nature 1970, 228:573.
7. Martin P.L., Sachs C., Hoberman A., Jiao Q., Bugelski P.J. Effects of CNTO530-erythropoietin mimetic- IgG4 fusion protein, on embryofetal development in rat and rabbits. Birth Defects Research Part B: Developmental and Reproductive Toxicology 2010, 89:87-96.
8. Martin P.L., Cornacoff J.B., Treacy G., Eirikas E., Marini J., White K.L., et al. Effects of administration of a monoclonal antibody against mouse tumor necrosis factor alpha during pregnancy and lactation on the pre- and postnatal development of the mouse immune system. International Journal of Toxicology 2008, 27:341-347.
9. Martin P.L., Breslin W., Rocca M., Wright D., Cavagnaro J. Considerations in assessing the developmental and reproductive toxicity potential of biopharmaceuticals. Birth Defects Research Part B: Developmental and Reproductive Toxicology 2009, 86:176-203.
10. Armour K.L., Clark M.R., Hadley A.G., Williamson L.M. Recombinant human IgG molecules lacking Fcgamma receptor I binding and monocyte triggering activities. European Journal of Immunology 1999, 29:2613-2624.
11. Armour K.L., Atherton A., Williamson L.M., Clark M.R. The contrasting IgG-binding interactions of human and herpes simplex virus Fc receptors. Biochemical Society Transactions 2002, 30:495-500.
12. Roopenian D.C., Akilesh S. FcRn: the neonatal Fc receptor comes of age. Nature Reviews Immunology 2007, 7:715-725.
13. Ober R.J., Radu C.G., Gheti V., Ward E.S. Differences in promiscuity for antibody-FcRn interactions across species: implications for therapeutic antibodies. International Immunology 2001, 13:1551-1559.
14. Andersen J.T., Daba M.B., Berntzen G., Michaelsen T.E., Sandlie I. Cross species binding analyses of mouse and human neonatal Fc receptor show dramatic differences in immunoglobulin G and albumin binding. Journal of Biological Chemistry 2010, 285:4826-4836.
15. Shah U., Dickinson B.L., Blumberg R.S., Simister N.E., Lencer W.I., Walker W.A. Distribution of the IgG Fc receptor, FcRn, in the human fetal intestine. Pediatric Research 2003, 53:295-301.
16. Jaffe L., Jeannote L., Bikoff E.K., Robertson E.J. Analysis of beta-2 microglobulin gene expression in the developing mouse embryo and placenta. Journal of Immunology 1990, 145:3474-3482.
17. DeSesso J.M. Comparative features of vertebrate embryology. Developmental and reproductive toxicology: a practical approach 2006, 147-197. Taylor & Francis, Boca Raton. 2nd ed. R.D. Hood (Ed.).
18. Dancis J., Lind J., Oratz M., Smolens J., Vara P. Placental transfer of proteins in human gestation. American Journal of Obstetrics and Gynecology 1961, 82:167-170.
19. Jauniaux E., Jurkovic D., Gulbis B., Liesnard C., Lees C., Campbell S. Materno-fetal immunoglobulin transfer and passive immunity during the first trimester of human pregnancy. Human Reproduction 1995, 10:3297-3300.
20. Wang H, Schuetz C, Akihiro A, Woods C, Xiao J, Iyer S, et al. Assessment of placental transfer and the effect on embryo-fetal development of a humanized monoclonal antibody targeting lymphotoxin-alpha in non-human primates. Late-breaking abstract poster presentation at the 50th annual meeting of the society of toxicology; 2011. p. 2772-844.
21. Malek A., Sager R., Kuhn P., Nicholaides K.H., Schneider H. Evolution of maternofetal transport of immunoglobulins during human pregnancy. American Journal of Reproductive Immunology 1996, 36:248-255.